Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
16.08
-0.04 (-0.25%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Aurinia Pharmaceuticals Employees
Aurinia Pharmaceuticals had 128 employees as of December 31, 2025. The number of employees decreased by 2 or -1.54% compared to the previous year.
Employees
128
Change (1Y)
-2
Growth (1Y)
-1.54%
Revenue / Employee
$2,433,648
Profits / Employee
$2,454,016
Market Cap
2.14B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 128 | -2 | -1.54% |
| Dec 31, 2024 | 130 | -170 | -56.67% |
| Dec 31, 2023 | 300 | 0 | - |
| Dec 31, 2022 | 300 | 0 | - |
| Dec 31, 2021 | 300 | 6 | 2.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 647 |
| Vericel | 398 |
| UroGen Pharma | 300 |
| Zymeworks | 231 |
| Zenas BioPharma | 167 |
| Kodiak Sciences | 141 |
| Mesoblast | 108 |
| Rapport Therapeutics | 84 |
AUPH News
- 4 days ago - LB Pharmaceuticals appoints Joseph Miller as CFO - TheFly
- 19 days ago - Aurinia settles patent litigation with Teva - TheFly
- 19 days ago - Aurinia Settles Patent Litigation with Teva - Business Wire
- 4 weeks ago - Aurinia Pharmaceuticals price target raised to $16 from $15 at RBC Capital - TheFly
- 4 weeks ago - Aurinia Pharmaceuticals sees FY26 revenue $315M-$325M, consensus $325.82M - TheFly
- 4 weeks ago - Aurinia Pharmaceuticals reports Q2 EPS 28c, consensus 24c - TheFly
- 4 weeks ago - Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress - Business Wire
- 4 weeks ago - Aurinia Pharmaceuticals Earnings release: Q2 2026 - Filings